NRx and Israel Developing Covid-19 Vaccine to Attack Variants

NRx Pharmaceuticals CEO Dr. Jonathan Javitt says they are working with Israel on a Covid-19 vaccine that targets Covid variants. He says vaccines from last year are becoming less effective.
Bloomberg Markets news video.

____________________

Covid 19 Virus Defend Systems from EcoTechN.com

______________

NEW YORK MIDTOWN TRIBUNE NEWS POLITICS 

BUSINESS SOCIETY CRIME CULTURE USA